老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vivos Therapeutics

4.12
-0.2800-6.36%
盘后：4.120.00000.00%19:40 EDT
成交量：12.40万
成交额：51.59万
市值：3,091.98万
市盈率：-2.32
高：4.41
开：4.34
低：3.95
收：4.40
52周最高：7.95
52周最低：1.98
股本：750.48万
流通股本：543.42万
量比：1.65
换手率：2.28%
股息：- -
股息率：- -
每股收益(TTM):-1.7775
每股收益(LYR):-2.2184
净资产收益率：-262.05%
总资产收益率：-42.48%
市净率：6.75
市盈率(LYR):-1.86

数据加载中...

总览公司新闻公告
2021/05/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/27

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/02

重要事件披露

8-K - Current report
2021/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/02/19

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/15

重要事件披露

8-K - Current report
2020/12/09

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/09

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/27

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/25

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/19

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/09

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/09

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933